Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 2
2006 3
2007 1
2008 1
2009 3
2010 1
2011 5
2012 2
2013 6
2014 4
2015 3
2016 4
2017 3
2018 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
Bishop JL, Thaper D, Vahid S, Davies A, Ketola K, Kuruma H, Jama R, Nip KM, Angeles A, Johnson F, Wyatt AW, Fazli L, Gleave ME, Lin D, Rubin MA, Collins CC, Wang Y, Beltran H, Zoubeidi A. Bishop JL, et al. Among authors: Kuruma H. Cancer Discov. 2017 Jan;7(1):54-71. doi: 10.1158/2159-8290.CD-15-1263. Epub 2016 Oct 26. Cancer Discov. 2017. PMID: 27784708 Free article.
Time Trends in Histological Features of Latent Prostate Cancer in Japan.
Kimura T, Takahashi H, Okayasu M, Kido M, Inaba H, Kuruma H, Yamamoto T, Furusato B, Furusato M, Wada T, Egawa S. Kimura T, et al. Among authors: Kuruma H. J Urol. 2016 May;195(5):1415-1420. doi: 10.1016/j.juro.2015.11.068. Epub 2015 Dec 8. J Urol. 2016. PMID: 26678955
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.
Peacock JW, Takeuchi A, Hayashi N, Liu L, Tam KJ, Al Nakouzi N, Khazamipour N, Tombe T, Dejima T, Lee KC, Shiota M, Thaper D, Lee WC, Hui DH, Kuruma H, Ivanova L, Yenki P, Jiao IZ, Khosravi S, Mui AL, Fazli L, Zoubeidi A, Daugaard M, Gleave ME, Ong CJ. Peacock JW, et al. Among authors: Kuruma H. EMBO Mol Med. 2018 Feb;10(2):219-238. doi: 10.15252/emmm.201707689. EMBO Mol Med. 2018. PMID: 29348142 Free PMC article.
Do androgen deprivation and the biologically equivalent dose matter in low-dose-rate brachytherapy for intermediate-risk prostate cancer?
Tabata R, Kimura T, Kuruma H, Sasaki H, Kido M, Miki K, Takahashi H, Aoki M, Egawa S. Tabata R, et al. Among authors: Kuruma H. Cancer Med. 2016 Sep;5(9):2314-22. doi: 10.1002/cam4.820. Epub 2016 Jul 25. Cancer Med. 2016. PMID: 27456710 Free PMC article.
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
Shiota M, Fujimoto N, Imada K, Yokomizo A, Itsumi M, Takeuchi A, Kuruma H, Inokuchi J, Tatsugami K, Uchiumi T, Oda Y, Naito S. Shiota M, et al. Among authors: Kuruma H. J Natl Cancer Inst. 2016 Feb 8;108(7). doi: 10.1093/jnci/djw005. Print 2016 Jul. J Natl Cancer Inst. 2016. PMID: 26857528
Prospective comparison of the efficacy of caudal versus periprostatic nerve block, both with intrarectal local anesthesia, during transrectal ultrasonography-guided prostatic needle biopsy.
Urabe F, Kimura T, Shimomura T, Onuma H, Yamamoto T, Sasaki H, Miki J, Kuruma H, Miki K, Egawa S. Urabe F, et al. Among authors: Kuruma H. Scand J Urol. 2017 Aug;51(4):245-250. doi: 10.1080/21681805.2017.1318299. Epub 2017 Apr 26. Scand J Urol. 2017. PMID: 28443752
Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M, Itsumi M, Takeuchi A, Imada K, Yokomizo A, Kuruma H, Inokuchi J, Tatsugami K, Uchiumi T, Oda Y, Naito S. Shiota M, et al. Among authors: Kuruma H. Endocr Relat Cancer. 2015 Dec;22(6):889-900. doi: 10.1530/ERC-15-0225. Epub 2015 Aug 26. Endocr Relat Cancer. 2015. PMID: 26311513
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer.
Shiota M, Bishop JL, Takeuchi A, Nip KM, Cordonnier T, Beraldi E, Kuruma H, Gleave ME, Zoubeidi A. Shiota M, et al. Among authors: Kuruma H. Oncotarget. 2015 Apr 20;6(11):9086-98. doi: 10.18632/oncotarget.3602. Oncotarget. 2015. PMID: 25871401 Free PMC article.
[New marker proteins for prostate cancer].
Hayashi N, Kuruma H, Egawa S. Hayashi N, et al. Among authors: Kuruma H. Nihon Rinsho. 2011 Jun;69 Suppl 5:140-4. Nihon Rinsho. 2011. PMID: 22207959 Review. Japanese. No abstract available.
[New biomarkers for the prostate cancer].
Ishii G, Kimura T, Kuruma H, Egawa S. Ishii G, et al. Among authors: Kuruma H. Nihon Rinsho. 2012 May;70(5):828-32. Nihon Rinsho. 2012. PMID: 22620008 Review. Japanese.
37 results
Jump to page
Feedback